Brought to you by 
U3 Pharma gets $4.5mm in Series A round
08 Jun 2012
Executive Summary
Newly formed U3 Pharma (signal transduction) raised $4.5mm (Euro5mm) in its Series A round of financing to industry investors led by Alta Partners and Medicis Ventures. BioM AG and private individuals from the biotech industry also participated.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
-
Drug Discovery Tools
- Genomics-Proteomics
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
U3 Pharma gets $4.5mm in Series A round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice